September 2025: Fitch affirmed Universal Corporation’s BBB- issuer rating. Outlook Negative
Fitch Ratings affirmed all ratings for Universal Corporation, including the company’s Long-Term Issuer Default Rating (IDR) at “BBB-“. The Rating Outlook is Negative.
Universal is the leading global supplier of compliant leaf tobacco products with a broad suite of value-added services. The ratings are constrained by its EBITDA scale, secular volume declines in global tobacco consumption and low margins. The negative outlook reflects elevated Fitch-adjusted EBITDA leverage in recent years and an expected level in the high 2x range for FY26 (ended March 31, 2025). A lack of clarity on, or an inability to reduce leverage down to 2.5x exiting 2026 calendar year – which would require sustaining EBITDA in the high $200 million range and using FCF for debt reduction – could lead to a ratings downgrade.
Key Rating Drivers:
– Increased Leverage: Fitch-adjusted EBITDA leverage has increased over the last several years following acquisitions during FY20-FY22 and significant working-capital usage during FY22-FY24. FCF deficits in recent years were driven by higher green tobacco pricing, combined with accelerated purchases in Brazil and higher receivables in Africa during FY24, leading to increased debt levels and EBITDA leverage in the low- to mid-3x range. EBITDA leverage remained elevated at 3.6x in FY25, reflecting increased revolver borrowings to support higher cash levels as a liquidity buffer given concerns over the Mozambique investigation, which has since been resolved and did not lead to any financial restatements. FY25 leverage would have been closer to 2.9x assuming normalized cash levels in the $60 million range, compared to the actual cash balance of $260 million at fiscal year-end.
– Leverage Moderating: Fitch projects Universal would need to maintain EBITDA in the high $200 million area combined with significant debt reduction over FY26 and FY27 to achieve EBITDA leverage in the mid-2x range over the next 12-18 months. Inherent volatilities within Universal’s business, including tobacco pricing and crop conditions, can affect cash flows. Therefore, the pace, timing, and amount of EBITDA growth, FCF generation, and debt repayment remains a risk. Fitch assumes the company would direct excess FCF toward debt repayment while maintaining cash balances in the $50 million to $60 million range, comparable to normalized historical levels. Fitch expects positive FCF generation of within $100 million annually over the medium term, assuming no significant working-capital swings. In FY26, Fitch expects working-capital tailwinds from the moderation in green tobacco pricing and more normalized tobacco buying cycles to be partially offset by larger crop sizes.
– Leading Global Position: Universal has the leading global position in tobacco leaf procurement, with defensible, long-term customer relationships and solid barriers to entry. Its global footprint across key tobacco-growing geographies enables the company to effectively navigate challenging supply chain and crop conditions to meet customer needs. Its focus on global sourcing, agronomy services, processing capabilities, and logistics expertise are key competitive strengths supporting its ability to grow share over the longer term.
– EBITDA Cycle Range: Fitch views Universal’s peak to trough EBITDA to be in the $250 million to $300 million range for its tobacco business and absent material contribution from the ingredients segment. The midpoint of this range may increase over time due to factors including the successful growth of Universal’s ingredients segment and share gains within the tobacco business. EBITDA is projected to moderate to the high $200 million range in FY26 and sustain at similar levels over the medium term, down from the low $300 million range in FY25 from moderating green tobacco pricing.
– Plant-Based Diversification Strategy: Fitch views Universal’s diversification into plant-based ingredients through three acquisitions completed during FY20-FY22 as supportive of its business profile and longer-term EBITDA growth prospects if well executed. Near-term profitability is moderate, with $12 million of operating income contribution in FY25. Fitch expects modest growth in this segment over the medium term, supported by new business wins, completion of the Lancaster facility expansion, and other R&D and product innovation opportunities.
– Share Gains Offset Secular Pressures: Global cigarette consumption continues to trend lower, with expected longer-term declines in the low single digits pressuring industry demand for tobacco leaf sourcing and processing. Despite this, Universal has maintained relatively steady volumes over the past several years by gaining share, increasing services offered to customers, and leveraging supply chain efficiencies to mitigate secular headwinds. Fitch believes Universal’s solid competitive position and exposure to next-generation nicotine products could enable further market share gains.
– Through-the-Cycle View: Universal’s rating incorporates credit protection measures and profitability through the cycle, as operating earnings and leverage can fluctuate. Unpredictable factors, such as tobacco leaf diseases and weather, can influence the price, yield and quality of tobacco leaf in any given year. Annual production levels and end-user demand vary and determine global supply conditions. When combined with shipment timing variability and foreign currency fluctuations, these factors can cause EBITDA volatility.
Peer Analysis:
Universal and Pyxus International are the only two global tobacco leaf suppliers that operate in all key regions for tobacco production. Pyxus has a smaller scale compared to Universal with a higher cost structure that generates weaker profitability. The remaining industry participants are local or regional distributors that lack the infrastructure to expand into other key regions, along with the financial resources and ability to offer a sustainable supply of compliant leaf tobacco and value-added services, which differentiate Universal from smaller competitors.
In the tobacco sector, Altria Group can be considered as a peer. Altria’s “BBB/Stable” rating reflects its significant EBITDA scale and leadership in the U.S. cigarette market, driven by its Marlboro franchise and leading positions in oral tobacco products. The rating also considers Altria’s strong profitability and cash flow, supported by consistent pricing power. Altria’s reliance on the U.S. market limits geographic diversification and increases regulatory risk exposure, constraining its business profile. Fitch expects Altria to maintain a consistent capital allocation framework that favors shareholders, while sustaining EBITDA leverage around 2x.
Key Assumptions:
– Consolidated revenue could decrease modestly in the low to mid-single digits in FY26 driven by the moderating green tobacco prices as supply and demand conditions move to a more balanced position. Revenue is projected to remain in the $2.8 billion to $2.9 billion range over the medium term driven by solid tobacco demand environment and good growth within the ingredients segment supported by new business wins, the Lancaster facility expansion, and other R&D and product innovation opportunities.
– EBITDA is projected to moderate to the high $200 million range in FY26, down from the low $300 million range in FY25 driven primarily by moderating green tobacco pricing. EBITDA in FY25 was supported by good tobacco leaf demand with tight supply conditions and higher prices.
– Fitch expects positive FCF generation of within $100 million annually, assuming no significant working-capital swings. In FY26, Fitch expects working-capital tailwinds from the moderation in green tobacco pricing and more normalized tobacco buying cycles to be partially offset by larger crop sizes.
– Universal has exposure to variable rates through its term loans, revolving facilities, and uncommitted international facilities. It uses interest rate swap agreements to convert a portion of the variable benchmark rate to a fixed rate on their term loans through their respective maturity dates. Fitch’s forecast assumes SOFR rates in the mid-3% to mid-4% range over the near to medium term.
– EBITDA leverage is projected to decline toward the mid-2x range over the medium term. Fitch assumes the company would direct excess FCF toward debt repayment while maintaining cash balances in the $50 million to $60 million range, comparable to normalized historical levels.
Rating Sensivities:
– Factors that Could, Individually or Collectively, Lead to Negative Rating Action/Downgrade: EBITDA leverage expected to be sustained above 2.5x exiting calendar 2026 due to financial performance, including EBITDA and FCF below Fitch’s expectations, significant working-capital or inflationary pressures, lower-than-anticipated debt paydown, or additional debt-funded M&A.
– Factors that Could, Individually or Collectively, Lead to Positive Rating Action/Upgrade: Materially larger operating scale in terms of revenue and EBITDA, reflecting increased portfolio diversification toward higher-growth and higher-margin categories, with a commitment to operating with EBITDA leverage below 2.0x.
Liquidity and Debt Structure:
As of June 30, 2025, Universal’s sources of liquidity included $355 million availability on the $530 million revolving credit facility and $178.4 million in cash and cash equivalents, which can vary seasonally and is primarily in the U.S. Additional liquidity is available from uncommitted lines of credit that support working-capital requirements internationally, under which ~$86 million were unused and available.
Universal’s cash flows can be variable, moving in conjunction with working-capital requirements mainly driven by fluctuating inventory costs influenced by tobacco leaf pricing and customer purchasing patterns. FCF was an inflow of $167 million in FY25, compared to outflows of $230 million in FY24, $153 million in FY23 and $98 million in FY22. Access to sufficient external liquidity to address variable working-capital needs is therefore a key credit consideration. In FY26, Fitch anticipates working-capital tailwinds from the moderation in green tobacco pricing and more normalized tobacco buying cycles to be partially offset by larger crop sizes.
Fitch also expects Universal will target uncommitted tobacco inventory levels within its long-term target of 20% of total tobacco inventory, which limits pricing risk with excess inventory. At June 30, 2025, Universal’s uncommitted tobacco inventories were about 11% of total tobacco inventory.
July 2025: S&P Global affirmed Universal Corporation‘s BBB- issuer credit rating. Outlook Negative
S&P Global Ratings affirmed BBB- issuer credit rating on Universal Corporation with Negative outlook – which reflects the potential for a lower rating if increased volatility of tobacco profitability results in leverage sustained above 3x or a weaker business risk profile, or if the company does not remedy its internal control deficiencies.
Summary:
Richmond, Virginia-based tobacco leaf merchant and plant-based ingredients producer Universal Corp.’s credit measures were stronger than expected in FY25 (ended March 31, 2025) with S&P Global Ratings-adjusted leverage declining to 2.6x due improved performance in its tobacco operations segment. S&P believes the tobacco growing environment for FY26 will normalize with more balanced industry supply conditions, potentially leading to lower margins and preventing the company from sustaining lower leverage. Moreover, despite improved performance, the company disclosed two separate instances of material weaknesses of internal controls in 2024 related to an embezzlement scheme from a senior finance employee in Mozambique as well as deficiencies related to physical counts of inventory for dark air-cured tobacco leaf in the Dominican Republic. While the overall financial impact of these internal control issues was limited and the company has made progress on remediation, S&P views these disclosures negatively from a governance perspective.
Assessment details:
In FY25, Universal’s operating performance in its tobacco operations segment was stronger than expected. The company’s tobacco cost position in FY25 was favorable due to an effective pre-buy of the Brazilian tobacco crop in 2024, which bolstered tobacco sales and operating margins in an undersupplied market with historically high green tobacco prices. Because the company was able to secure significant inventory in an undersupplied market, tobacco sales and operating income grew 7% and 8%, respectively. Notwithstanding this strong performance, S&P expects industry supply conditions to revert from under-supply to balanced supply in FY26, which will likely lead to lower green tobacco prices. Although the company can partially offset lower prices with higher volume and market share gains, S&P remains cautious about the company’s positive market share outlook amid declining global demand. S&P expects tobacco operating margins will contract about 60 basis points (bps) in FY26 as the company navigates a more competitive market with potentially more volatile green tobacco prices. Volatility of tobacco profitability is a key risk to the rating, as is the risk of declining tobacco leaf sales due to less global consumption. Therefore, S&P monitors these risks to see how well management can mitigate them so that it can continue to reduce and sustain leverage at levels that support the rating.
Universal’s leverage only recently declined below the 3x downside trigger. Given the expectation for moderating tobacco operations segment performance, including an overall consolidated S&P Global Ratings-adjusted EBITDA decline of about 6% in fiscal 2026, S&P anticipates that leverage will increase to 2.8x by end-FY26. Moreover, the company has not established a recent track record of maintaining leverage below 3x since the trigger was breached in Q1 2024 and peaked at 3.6x in Q1 2025. S&P believes there is downside risk to the base case if margins decline due to volatile green tobacco prices or if volumes are pressured because of reduced customer demand with a more plentiful global crop, which could increase leverage above the 3x downside trigger again. For this reason, S&P maintains the negative outlook until there is a sustained track record of operating below 3x leverage.
Universal focuses on growing its ingredients operations segment organically, but improved performance in the segment will not drive leverage reduction. During FY25, Universal completed a major expansion project at its Lancaster, Pennsylvania facility, which added capabilities in extraction, blending, and aseptic packaging. The company is shifting its focus from platform building to organic growth by strengthening its sales, marketing, and product development teams to stimulate commercial activity. Segment operating income tripled to $12.3 million from a low base, primarily due to higher volumes and product mix shift to value-added products from commodity-based ingredients. After years of focus on platform investments after the acquisitions of Shank’s, Silva, and FruitSmart, Universal continues to incrementally grow volumes and margins in the ingredients segment with this strategic shift; however, overall contribution to total profitability from ingredients is set to remain modest.
Governance factors are a moderately negative consideration due to recent material weaknesses in internal controls. In FY25, a senior finance employee in Mozambique perpetrated an embezzlement scheme and was able to extract $16.7 million in stolen funds between fiscal years 2016 and 2025, which prompted the company to hire external auditors to assess the damage and evaluate internal controls. The incident resulted in delayed quarterly SEC filings for the Q2 and Q3 2025, as well as modest one-time costs for legal expenses and forensic accounting. That said, a remediation plan was quickly put in place, and the overall financial effect of the embezzlement did not result in material misstatements and had a negligible impact on leverage. As of end-FY25, the issue is remediated. The company also disclosed deficiencies related to physical counts of dark air-cured tobacco leaf at its Dominican Republic subsidiary. A remediation plan has been put into place, and the new internal controls will be tested over the coming quarters, but a determination on the effectiveness has not been made yet. Despite only modest financial impact from these issues so far, S&P views the trend of internal control weaknesses as a negative governance consideration, and revises the overall management and governance assessment to moderately negative. There is no impact to the issuer credit rating yet, but S&P monitors the company’s progress on remediation of the new internal control weakness. If further governance deficiencies are identified, S&P could lower the ratings, especially if weak internal controls result in material misstatements or have a more material impact on the company’s operating performance and credit metrics.
The negative outlook reflects the potential for a lower rating if increased volatility of tobacco profitability results in leverage sustained above 3x or a weaker business risk profile, or if the company does not remedy its internal control deficiencies.
S&P could lower the ratings if the company sustains leverage above 3x, or if S&G views the company’s competitive position less favorably either because of declining global tobacco demand or more volatile profitability. S&P could alsolower the rating if deficiencies related to internal controls persist. This could occur if:
– The company’s core tobacco operations underperform expectations;
– The company has problems managing its working capital position;
– Global tobacco demand declines faster than expected, resulting in lower volumes and top-line pressure, or big tobacco customers begin to increase leaf merchanting business;
– New material management and governance deficiencies arise; or
– The company’s capital allocation favors shareholder returns over debt reduction, or it pursues debt-funded acquisitions.
S&P could revise the outlook to stable if the company sustains leverage below 3x, and the view of profitability and competitive position are unchanged. This could occur if:
– The company’s core tobacco operations continue to execute and global demand for tobacco remains stable such that this segment’s EBITDA is not adversely affected;
– The company’s seasonal working capital requirements remain manageable; and
– The company executes on its strategy for the ingredients business and increases EBITDA contribution from this segment to the overall business.
